LSL Pharma Inc. announces that its subsidiary LSL Laboratory (?LSL?) has received new orders for natural health products. Unless otherwise specified, all amounts are in Canadian dollars. These new orders reflect the addition of new clients, as well as volume increases from certain existing clients.

In addition to benefits from the higher production capacity stemming from the relocation of LSL?s activities to a new facility in La Pocatière, the Company?s solid reputation enabled it to take advantage of favorable market conditions. Based on purchase orders received up to this date, the Company believes that the positive effect on its sales could exceed $2.6 million on an annual basis beginning gradually in the first quarter of 2024. In addition, LSL Pharma Group is engaged in negotiations for potential additional orders related to natural health products.

Should all discussions be successful, these orders could result in annual sales of approximately $1.5 million.